Based on our previous study on the development of the furoquinolinedione and isoxazoloquinolinedione TDP2 inhibitors, the further structure-activity relationship (SAR) was studied in this work. A series of furoquinolinedione and isoxazoloquinolinedione derivatives were synthesized and tested for enzyme inhibitions. Enzyme-based assays indicated that isoxazoloquinolinedione derivatives selectively showed
基于我们之前对
呋喃喹啉二酮和
异恶唑并
喹啉二酮 TDP2
抑制剂开发的研究,本工作进一步研究了构效关系 (
SAR)。合成了一系列
呋喃喹啉二酮和
异恶唑并
喹啉二酮衍
生物并测试了酶抑制作用。基于酶的测定表明,
异恶唑并
喹啉二酮衍
生物在亚微摩尔范围内选择性地显示出高 TDP2 抑制活性,
呋喃喹啉二酮衍
生物在低微摩尔范围内选择性地显示出高 TDP2 抑制活性。最有效的 3-(3,4-二
甲氧基苯基)
异恶唑并[4,5-g]
喹啉-4,9-二酮 ( 70 ) 显示出 TDP2 抑制活性,IC 50为 0.46 ± 0.15 μM。这项工作将促进未来发现
异恶唑并
喹啉二酮 TDP2 选择性
抑制剂的努力。